G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,401,000 | -93.9% | 84,400 | -93.0% | 0.00% | -100.0% |
Q4 2018 | $23,114,000 | -63.6% | 1,207,000 | -0.7% | 0.01% | -60.0% |
Q3 2018 | $63,532,000 | +44.3% | 1,215,000 | +19.9% | 0.02% | +66.7% |
Q2 2018 | $44,025,000 | +150.2% | 1,013,000 | +113.3% | 0.01% | +125.0% |
Q1 2018 | $17,599,000 | – | 475,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |